Company Research Report: Dar Aldawa

Company Overview

• Name: Dar Aldawa

• Mission: Dar Aldawa is a leading pharmaceutical company dedicated to serving patients, healthcare professionals, and payers worldwide.

• Vision: Dar Aldawa aims to become the foremost pharmaceutical partner for key stakeholders keen on improving health outcomes, cost of care, and the well-being of patients and their caregivers.

• Values: Quality, Accountability, Transparency, Ethics, Integrity, with a core belief that “Human Life Quality Matters”.

• Founded: Nearly 50 years ago.

• Founder: No information is available.

• Key People:

• Akram Jerab, Chairman of the Board of Directors

• Khaled Harb, Chief Executive Officer

• Mohammed Alsous, Chief Operating Officer

• Shadi Saqfelhait, Chief Financial Officer

• Fares Matar, Marketing Director

• Manar Alasaad, Research and Development Director

• Dana Alshishani, Organizational Development Senior Director

• Ahmad Alfaqieh, General Manager - Algeria

• Additional Board Members include Osama Yaish, Mohannad Jerab, Lina Jardaneh, Taghreed Al-Shunnar, Sameh Qasem Al-Nassir, Issam Sangalawi, Mounther Nabulsi, Ramzi Salfity, Zaid Abdo Nassif, and Adnan Al Sawaier.

• Headquarters:

• Jordan: P.O Box: 9364 Amman Naour 11191 Jordan

• Algeria: Algiers, Route Bouchaoui, Property no 484, Section 01 Ouled Fayet

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Specializing in the development, manufacturing, marketing, and distribution of high-quality pharmaceutical and consumer healthcare products. They have operations in major markets like the Middle East, North Africa, and Europe.

Products

Dar Aldawa offers a wide range of pharmaceutical products across various therapeutic categories. Below is a high-level description of some of their product offerings:

Anti-Infectives

• Claridar: Clarithromycin suspension and tablets for bacterial infections.

• Mixif: Cefixime capsules and suspension for treating infections.

• Clavodar: Amoxicillin with Clavulanic Acid for bacterial infections.

Cardiovascular & Diabetes

• Gizlan: Formulations of Irbesartan for blood pressure management.

• Glunorm: Vildagliptin and combination with Metformin for diabetes management.

• Rozitta: Rosuvastatin tablets to manage cholesterol levels.

Urology

• Gamcet: An alpha-blocker with Tamsulosin for prostate issues.

• Tyra: Tadalafil as a treatment for erectile dysfunction.

Respiratory

• Liblab: Dried Ivy Leaf Extract syrup for respiratory conditions.

• Aresil: Nasal Spray with Mometasone Furoate for allergies.

Gastrointestinal

• Famodar: Famotidine tablets for reducing stomach acid.

• Pantodar: Pantoprazole tablets for acid-related digestive issues.

Central Nervous System

• Risdone: Risperidone for mental health conditions.

• Epigab: Pregabalin capsules for neuropathic pain.

Dermatology

• Hairgrow: Minoxidil solution for treating hair loss.

• Smooderm: Tretinoin cream for treating acne.

Ophthalmology

• Ophtazolin: Eye drops containing Antazoline and Naphazoline.

Oncology

• Atrenova: Bortezomib vials for cancer treatment.

• Dadas: Dasatinib tablets for leukemia treatment.

Recent Developments

• Dar Aldawa participated in various international events and collaborations, notably signing cooperation agreements with institutions like the University of Petra and Zarqa University.

• They have expanded regional presence by obtaining licenses for regional headquarters in Saudi Arabia.

• The company supports social causes, contributing significant donations to aid Gaza and Syrians affected by natural disasters.

• Engaged in educational and industry-related symposiums and conferences, such as the annual Jeddah Dermatology event and the "Pharmaconex" Conference in West Africa.

• New Products or Features Launched: No specific new products or features mentioned.

• New Partnerships:

• Signed sponsorship and cooperation agreements with universities and clubs, enhancing their regional alliances and educational engagement.

Dar Aldawa has a strong commitment to innovation, quality, and contributing positively to society, with a focus on expanding its reach and impact in the pharmaceutical industry while maintaining trusted relationships with patients and partners.